Safety Considerations & Who Should Receive MIC B12 Injections MIC B12 is appropriate for adults with confirmed or suspected B12 deficiency, particularly those with pernicious anemia, dietary insufficiency, or malabsorption
Clinical studies have confirmed that AOD-9604 does not stimulate IGF-1 production in any biological system tested, including human clinical trials monitoring serum IGF-1 levels over 24-week treatment periods
The C20 fatty diacid moiety enabling albumin binding extends the pharmacokinetic half-life to approximately 6-7 days, making once-weekly research dosing protocols practical
Who Might AOD 9604 Suit, and Who Should Be Cautious
The study also confirmed that AOD9604 works by inhibiting fat synthesis in liver and fat cells, providing additional mechanistic insight into how the peptide promotes metabolic health
Enhanced NAD+ levels may support improved mitochondrial efficiency, cellular energy production, and metabolic pathways related to fat utilization and vitality